Hunter Renfrow

Wide Receiver

Age: 28
Free Agency: 2025 (Void)
Accrued Seasons: 4
  • 2023 Salary Cap Charge: $13,126,000 (5.59% of cap)
  • 2023 Cash Payout: $11,549,000 (5.73% of spending)
  • 2023 Cash to Cap Ratio: 0.88
  • Contract Value: $31,700,000 ($15,850,000 APY)
  • Fully Guaranteed Money: $14,500,000
  • Contract Ranking: 18/313 at WR

Current Contract

(Extension, signed 2022)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202227$1,000,000$1,914,987$0$629,000$0$1,000,000$3,543,9871.7%
2023 📝
March 17: Roster bonus due
28$6,500,000$1,836,000$4,320,000$629,000$100,000$10,820,000$13,126,0005.6%
202429$11,153,000$1,836,000$0$629,000$100,000$0$13,718,0005.2%
2025 📝
February 10: Contract voids
30Void$1,836,000VoidVoidVoidVoid$3,672,0001.3%
202631Void$1,836,000VoidVoidVoidVoid$00.0%
Total$18,653,000$9,258,987$4,320,000$1,887,000$200,000$11,820,000$34,059,987

Contract Notes

Hunter Renfrow signed a two year contract extension with the Raiders worth $31.7 million. Renfrow received $21 million in guaranteed salary of which $14.5 million is fully guaranteed. If on the roster on the 3rd day of the 2023 league year Renfrow will have his salary for 2023 fully guaranteed. The final two years of the contract are void years for salary cap purposes.

Cash Flows

- old money
- fully earned money
- unearned or partially earned money
$15.9M
$31.7M
Old Money202220232024
Cash Due$259,000$8,010,000$11,549,000$11,882,000
Running Cash$8,269,000$19,818,000$31,700,000
Career Earnings: $12,885,948
Career APY: $3,221,487
Potential Earnings: $36,316,948
Total Guarantees: $14,815,948
Largest Cash Payment: $11,882,000 (2024)
Largest Cap Number: $13,718,000 (2024)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RaidersDraftedExtended20194$2,835,948$708,987$315,948$2,335,94882.4%$778,649
RaidersExtensionActive20222$31,700,000$15,850,000$14,500,000$10,550,00033.3%$10,550,000
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Raiders4$12,885,948$3,221,487$5,800,9480.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2019Raiders$495,000$78,987$0$0$0$0$573,9870.3%$810,948
2020Raiders$675,000$78,987$0$0$0$0$753,9870.3%$675,000
2021Raiders$850,000$78,987$0$0$0$0$928,9870.5%$850,000
2022Raiders$1,000,000$1,914,987$0$629,000$0$1,000,000$3,543,9871.7%$10,550,000
2023Raiders$6,500,000$1,836,000$4,320,000$629,000$100,000$10,820,000$13,126,0005.6%$11,549,000
2024Raiders$11,153,000$1,836,000$0$629,000$100,000$0$13,718,0005.2%$11,882,000
2025Raiders$0$1,836,000$0$0$0$0$3,672,0001.3%$0
2026Raiders$0$1,836,000$0$0$0$0$00.0%$0
Total$20,673,000$9,495,948$4,320,000$1,887,000$200,000$11,820,000$36,316,948$36,316,948

Statistics

YearGames PlayedGames InactiveSnapsRushingReceivingFumbles
InjuredHealthyOffenseSpecialAttYardsAvgTDRecYardsAvgTDTotalLost
2019133042.9%3.7%000.004960512.3410
2020160050.8%11.3%000.005665611.7200
2021170066.5%15.7%331.00103103810.1900
2022102034.2%5.7%000.00363309.2200
2023120038.5%0.7%000.00222099.5000

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$1,356,000$15,850,000
Injury Adjusted$1,356,000$15,850,000
test
OTC Valuation $4.4M $8.8M $13.2M $17.6M $22M APY $5M $10M $15M $20M $25M $9,783,000 $5,250,000

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.